Ursula A Germann

The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor.

Huai Gao, Yow-Ming Wang, Yow-Ming C Wang, 2011, ACS medicinal chemistry letters.

Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)

Paul Shapiro, Alex M Aronov, Mark Namchuk, 2017, Molecular Cancer Therapeutics.

Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control.

Xiaoling Xie, Jingrong Cao, Alex M Aronov, 2009, Journal of medicinal chemistry.

Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole.

Jian Wang, Tiansheng Wang, Mark Namchuk, 2009, Journal of medicinal chemistry.

Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors.

Xiaoling Xie, Jingrong Cao, Alex M Aronov, 2007, Journal of medicinal chemistry.